Company Samediab Srl with Fiscal Code 35489881
recorded a turnover of 2024 of
137.952,
with a net profit of
97.886
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Samediab Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
38.461
77.656
87.430
88.645
99.288
124.051
114.862
146.610
137.952
Total Income - EUR
-
38.462
77.660
87.433
88.648
99.792
124.067
114.886
146.646
138.075
Total Expenses - EUR
-
16.841
23.992
25.130
18.398
17.317
20.306
20.041
28.522
36.254
Gross Profit/Loss - EUR
-
21.621
53.668
62.303
70.250
82.474
103.761
94.845
118.124
101.821
Net Profit/Loss - EUR
-
20.733
52.891
61.428
69.364
81.532
102.669
93.754
116.732
97.886
Employees
-
1
1
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -5.4%, from 146.610 euro in the year 2023, to 137.952 euro in 2024.
The Net Profit decreased by -18.194 euro, from 116.732 euro in 2023, to 97.886 in the last year.
Check the financial reports for the company - Samediab Srl
Financial Rating - SAMEDIAB SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Samediab Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Samediab Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Samediab Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
100.023 euro in 2024 which includes Inventories of
0 euro, Receivables of
57.319 euro and cash availability of
42.705 euro.
The company's Equity was valued at
98.010 euro, while total Liabilities amounted to
4.296 euro.
Equity decreased by -18.194 euro, from 116.857 euro in 2023, to 98.010 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Samediab Srl